(MENAFN- GlobeNewsWire - Nasdaq) New York, May 25, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Menopause Market Report 2023-2033" -
The Menopause Market Report 2023-2033 : This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Growing Demand for Post-Menopause Drugs Owing to Rise in Geriatric Population
Some of the major forces propelling the menopause and post-menopause market include the aging population, rising awareness, technological advancements, and increasing healthcare spending drive demand for new and innovative solutions. With growing awareness about menopause and its symptoms, more women are seeking treatment options. The aging population is growing worldwide, and it is expected that the number of menopausal women will increase in the coming years. This presents a huge market opportunity for menopause drugs.
Lifestyles changes and sedentary habits have led to an increase in menopausal symptoms as women suffer from symptoms such as insomnia, erratic mood changes and hot flashes. This has led to a rise in demand for menopause drugs that can alleviate these symptoms. With new advancements in drug manufacturing and delivery methods, it is possible to create more effective and targeted menopause drugs with fewer side effects. Moreover, as healthcare expenditures increase globally, more women will have access to menopause drugs, which will drive the market further.
Misconceptions and Associated Side Effect Challenges to Hamper Industry Growth
Menopause is often stigmatized as a taboo subject and inadequately discussed. Women may feel embarrassed and uncomfortable discussing their symptoms, leading to a reluctance to seek treatment openly. Hormonal treatments for menopause may have adverse side effects, such as increased risk of cancer and heart-related problems, leading to safety concerns among patients. In addition to this, menopause products can be costly, making them inaccessible for some women. Health insurance might not be available for these products. Addressing these issues through education, product improvement, pricing strategies, and strategic marketing can significantly boost the growth of menopause products in the market.
What Questions Should You Ask before Buying a Market Research Report?
. How is the menopause market evolving?
. What is driving and restraining the menopause market?
. How will each menopause submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
. How will the market shares for each menopause submarket develop from 2023 to 2033?
. What will be the main driver for the overall market from 2023 to 2033?
. Will leading menopause markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
. How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
. Who are the leading players and what are their prospects over the forecast period?
. What are the menopause projects for these leading companies?
. How will the industry evolve during the period between 2023 and 2033? What are the implications of menopause projects taking place now and over the next 10 years?
. Is there a greater need for product commercialisation to further scale the menopause market?
. Where is the menopause market heading and how can you ensure you are at the forefront of the market?
. What are the best investment options for new product and service lines?
. What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the menopause market today, and over the next 10 years:
. Our 253-page report provides 109 tables and 154 charts/graphs exclusively to you.
. The report highlights key lucrative areas in the industry so you can target them – NOW.
. It contains in-depth analysis of global, regional and national sales and growth.
. It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the menopause market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
. In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
. You will find original analyses, with business outlooks and developments.
. Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising menopause prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely,“V”,“L”,“W” and“U” are discussed in this report.
Segments Covered in the Report
Treatment Type Outlook
. Dietary Supplements
. OTC Pharma Products
- Hormonal
- Non-Hormonal: Anti-depressants, Others
Distribution Channel
. Retail
. Online
. Institutional Sales
Stage
. Perimenopause
. Menopause
. Post-menopause
Route of Administration
. Topical
. Oral
. Injectables
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:
North America
. U.S.
. Canada
Europe
. Germany
. UK
. France
. Spain
. Italy
. Russia
. Rest of Europe
Asia Pacific
. China
. Japan
. India
. Australia
. South Korea
. Rest of Asia Pacific
Latin America
. Brazil
. Mexico
. Argentina
. Rest of Latin America
MEA
. GCC
. South Africa
. Rest of MEA
The report also includes profiles and for some of the leading companies in the Menopause Market, 2023 to 2033, with a focus on this segment of these companies' operations.
Leading companies and the potential for market growth
. Abbott
. AbbVie Inc.
. Bayer AG
. Cipla Inc.
. Eli Lily
. Emcure
. Glenmark Pharmaceuticals Limited
. Merck
. Novartis
. Novo Nordisk
. Padagis
. Pure Encapsulations, LLC
. Teva Pharmaceuticals Limited
. Theramex
. TherapeuticsMD
Overall world revenue for Menopause Market, 2023 to 2033 in terms of value the market will surpass US$17.33 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Menopause Market, 2023 to 2033 report help you?
In summary, our 250+ page report provides you with the following knowledge:
. Revenue forecasts to 2033 for Menopause Market, 2023 to 2033 Market, with forecasts for treatment type, distribution channel, stage, route of administration, each forecast at a global and regional level – discover the industry's prospects, finding the most lucrative places for investments and revenues.
. Revenue forecasts to 2033 for five regional and 18 key national markets – See forecasts for the Menopause Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Germany, France, UK, Italy, Russia, China, India, Japan, South Korea and Australia among other prominent economies.
. Prospects for established firms and those seeking to enter the market – including company profiles for 15 of the major companies involved in the Menopause Market, 2023 to 2033.
Read the full report:
About reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
